A detailed history of Wallace Advisory Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Wallace Advisory Group, LLC holds 6,996 shares of ABT stock, worth $713,801. This represents 0.58% of its overall portfolio holdings.

Number of Shares
6,996
Previous 7,101 1.48%
Holding current value
$713,801
Previous $688 Million 11.97%
% of portfolio
0.58%
Previous 0.54%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

SELL
$109.52 - $120.96 $11,499 - $12,700
-105 Reduced 1.48%
6,996 $770 Million
Q4 2023

Jan 08, 2024

SELL
$90.19 - $110.4 $30,394 - $37,204
-337 Reduced 4.53%
7,101 $688 Million
Q3 2023

Oct 05, 2023

BUY
$95.53 - $114.62 $12,514 - $15,015
131 Added 1.79%
7,438 $811 Million
Q1 2023

May 10, 2023

SELL
$96.86 - $114.01 $1,162 - $1,368
-12 Reduced 0.16%
7,307 $740 Million
Q4 2022

Feb 21, 2023

BUY
$95.06 - $111.52 $695,744 - $816,214
7,319 New
7,319 $804 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $179B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Wallace Advisory Group, LLC Portfolio

Follow Wallace Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wallace Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wallace Advisory Group, LLC with notifications on news.